PARE0020 Partnership with Ministry of Social Affair- Better Future for Patient in Msd
Authors: M. Jaakson
Journal: Annals of the Rheumatic Diseases (2014)

<h3>Background</h3> In EU 44 million workers now have MSDs- including back pain strains of the neck, shoulder and arms. This cost up to €240 bn annually in lost productivity and sickness absence, representing up to 2% of GDP across the EU. Nearly half of the sick leave is taken in MSDs, thus significantly impacting the economy, 2009. In the long arm, leg, back, or neck problems due to the limited capacity for work, 59% of workers aged 15-64 years. The coalition "Longer working for Estonia" has been called in order to keep a closer dialogue with representatives of the state of MSDs treatment remedy. AS RA, which cannot be prevented, and with non-inflammatory diseases, such as osteoporosis, that have a certain degree of prevention of the disease. Estonia, like many other countries have separate budgets for treatment, social support and unemployment benefits. Such a system does not support the preservation of the ability to work as a key objective. MSD is characterized by the fact that people are able to work due to illness will be treated quickly incapacitated without adequate, timely, resulting in high costs to society. If this is taken into account and contribute to an earlier interventional enough to be able to achieve a reduction in indirect costs. This means that efforts must be budget of treatment and the expected savings are expected in terms of social benefits. <h3>Objectives</h3> Main objectives are: 1. To support the continuation of the work under part load capabilities. 2. To motivate the employers that they would be interested in a permanent health problems in the working conditions necessary foundation. 3. Nationally, it must be ensured support for the rehabilitation of an employee health disorder, which is effective immediately after the occurrence of a major health problem and before a person determined by loss of earning capacity and disability. Both the patient and the physician, the first question should be: how can the patient continue its work so that his health condition does not worsen. This requires a cooperation of the patient, the employer and the clinician. Also point out to prevention, patient access to health systems, treatment, rehabilitation and social opportunities, the persistence of labor market, etc. <h3>Methods</h3> Coalition working group will meet four times a year. The meeting will examine all relevant issues relating to the treatment of the working age population in the labor market, and persistence. Then meet with Ministry of Social Affairs, to present and discuss the proposals, which help MSD patient, to improve the situation. <h3>Results</h3> In addition to discussions with the Ministry of Social Affair MSDs must find a place in the National Health Plan, which provides an integrated approach to MSDs, systemic prevention, treatment and social guarantees. <h3>Conclusions</h3> The government must reduction the cost and prioritize to patient, the employers and the labor market. Consideration should be given according to the National Plan of Action, where the priorities are early intervention, prevention, and treatment. Ministry of Social Affairs shall designate a responsible, engaged in the problem of MSD9s disease. <h3>References</h3> Zheltoukhova, K; Bevan, S. (2011) Fit for Work Estonia. <h3>Acknowledgements</h3> Estonian Rheumatism Association, Estonian Society for Rheumatology, Estonian Society of PRMD, Estonian Society of Family Doctors, Estonian Society of Occupational Health Physicians, Estonian Society of Traumatology and Orthopedics and Ministry of Social Affairs and The Work Foundation <h3>Disclosure of Interest</h3> M. Jaakson Employee of: CEO <h3>DOI</h3> 10.1136/annrheumdis-2014-eular.5075